Skip to main content

Advertisement

ADVERTISEMENT

News

News
07/20/2021
Telemedicine care for patients with schizophrenia and bipolar disorder suffering from reduced quality of life is not a significant treatment concept, according to a recent trial published in BMC Psychiatry.
Telemedicine care for patients with schizophrenia and bipolar disorder suffering from reduced quality of life is not a significant treatment concept, according to a recent trial published in BMC Psychiatry.
Telemedicine care for patients...
07/20/2021
Psych Congress Network
News
07/19/2021
A single dose of psilocybin given to mice produced an immediate and long-lasting increase in connections between neurons in the brain in a recent study conducted by researchers at Yale University.
A single dose of psilocybin given to mice produced an immediate and long-lasting increase in connections between neurons in the brain in a recent study conducted by researchers at Yale University.
A single dose of psilocybin...
07/19/2021
Psych Congress Network
News
07/09/2021
Three months of daily, add-on treatment with the oral glycine transporter-1 (GlyT1) inhibitor BI 425809 improved cognition in patients with schizophrenia.
Three months of daily, add-on treatment with the oral glycine transporter-1 (GlyT1) inhibitor BI 425809 improved cognition in patients with schizophrenia.
Three months of daily, add-on...
07/09/2021
Psych Congress Network
News
07/01/2021
Telemedicine care for patients with schizophrenia and bipolar disorder suffering from reduced quality of life is not a significant treatment concept, according to a recent trial published in BMC Psychiatry.
Telemedicine care for patients with schizophrenia and bipolar disorder suffering from reduced quality of life is not a significant treatment concept, according to a recent trial published in BMC Psychiatry.
Telemedicine care for patients...
07/01/2021
Psych Congress Network
News
06/29/2021
Lowering an antipsychotic dose below the standard range recommended for acute stabilization appears to increase relapse risk and all-cause discontinuation during maintenance treatment in multi-episode schizophrenia.
Lowering an antipsychotic dose below the standard range recommended for acute stabilization appears to increase relapse risk and all-cause discontinuation during maintenance treatment in multi-episode schizophrenia.
Lowering an antipsychotic dose...
06/29/2021
Psych Congress Network
News
06/24/2021
COVID-19 healthcare workers report elevated levels of anxiety symptoms.
COVID-19 healthcare workers report elevated levels of anxiety symptoms.
COVID-19 healthcare workers...
06/24/2021
Psych Congress Network
News
06/23/2021
Accurately diagnosing bipolar disorder goes beyond questionnaires and other screeners.
Accurately diagnosing bipolar disorder goes beyond questionnaires and other screeners.
Accurately diagnosing bipolar...
06/23/2021
Psych Congress Network
News
06/23/2021
Cognitive impairments are associated with commonly prescribed psychotropic medications with anticholinergic properties for patients with schizophrenia, according to new research.
Cognitive impairments are associated with commonly prescribed psychotropic medications with anticholinergic properties for patients with schizophrenia, according to new research.
Cognitive impairments are...
06/23/2021
Psych Congress Network
News
06/14/2021
Women at risk of postpartum showed altered brain connectivity in networks associated with goal-directed behavior compared with healthy women, according to a study.
Women at risk of postpartum showed altered brain connectivity in networks associated with goal-directed behavior compared with healthy women, according to a study.
Women at risk of postpartum...
06/14/2021
Psych Congress Network
News
05/11/2021
An oral dissolving film for sublingual or buccal administration of dexmedetomidine was effective and well-tolerated for the rapid treatment of acute agitation in patients with schizophrenia, according to a poster presented at the 2021 APA...
An oral dissolving film for sublingual or buccal administration of dexmedetomidine was effective and well-tolerated for the rapid treatment of acute agitation in patients with schizophrenia, according to a poster presented at the 2021 APA...
An oral dissolving film for...
05/11/2021
Psych Congress Network

Advertisement